Nasus Pharma (NSRX)

• Market cap: $54.3M
• 1 day: 12.41%
• 5 days: 11.86%
• 1 month: -15.07%
• 3 months: -28.92%
• 6 months: -42.18%
• Year to date: -38.81%
• 1 year: -44%
• 5 years: -44%
• 10 years: -44%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.